Clinical Research Networks
Explore SCRI's 12 clinical research networks across the Asia-Pacific region, connecting researchers in diseases of Asian significance.
Clinical research networks have become a critical platform to gather clinical evidence that has not been possible in the past with single sites.
SCRI’s development of networks in the Asia-Pacific region provides engagement opportunities in critically important and relevant research for diseases of Asian significance.
Networks facilitate and enhance the collaborative partnerships between academia, industry and the government. SCRI assists in connecting investigators with research interests in the same disease areas. We further support networks with our operational capabilities. SCRI endeavours to provide network participants the opportunity to develop high-impact research questions, acquire funding and be part of high quality research.
Presently, the 12 clinical research networks established are:
ASEAN Network of Adrenal Hypertension (ANAH)
Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group
Asia Pacific Cardiovascular Research (ASPIRE) Network
Asian Myeloma Network (AMN)
Asian Pediatrics Inflammatory Bowel Disease (PIBD) Research Network
Asian Thoracic Oncology Research Group (ATORG)
Deciphering Diversities: Renal Asian Genetics Network (DRAGoN)
GyneCologic Cancer Group Singapore (GCGS)
Inherited Cancers Network Asia (ICaN Asia)
Pan-Asian Resuscitation Outcomes Study (PAROS) Clinical Research Network
Pediatric Acute & Critical Care Medicine Asian Network (PACCMAN)
Singapore Myeloma Study Group (SMSG)